An Open-label Extension Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular Insert

Summary

This study evaluated the long-term (9-months) safety of the Bimatoprost Ocular Insert in participants with Glaucoma or Ocular Hypertension who completed study FSV5-004. All the participants received Bimatoprost Ocular Insert and wore it for approximately 3 months (12 weeks), then had that Insert removed and a new Insert placed for another 26 weeks (approximately 6 months).

Timeline

Start

2015-08-10

Primary completion

2016-08-11

Completion

2016-08-11

Drugs

Indications